Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ji-Mai-Xin versus active comparator for renal anemia in persistent peritoneal dialysis
ChiCTR2000034705Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epoetin alfa in Uraemic Anaemia (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Blood routine at 12 weeks. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
epoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on ChiCTR2000034705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034705.